SCHEMBL381471

SCHEMBL381471

CC(C)(C)N(C(=O)O)C(CN)c1ccccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 1/20 0.56
OPRM1 P35372 6/20 0.41
AOC3 Q16853 1/20 0.40
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
CYP2D6 P10635 1/20 0.39
NFKB1 P19838 1/20 0.39
HIF1A Q16665 1/20 0.39
BLM P54132 1/20 0.38
FDFT1 P37268 1/20 0.36
CXCL8 P10145 1/20 0.36
CASP1 P29466 1/20 0.35
ACP3 P15309 1/20 0.35
DPP4 P27487 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL381393 0.89 NISCH (0.43) NISCHCYP2D6NFKB1CXCL8
SCHEMBL382379 0.87 NISCH (0.43) NISCHOPRM1AOC3ADRB2ADRB1
SCHEMBL19244837 0.84 NISCH (0.41) NISCHOPRM1AOC3ADRB2ADRB1
SCHEMBL19244810 0.83 OPRM1 (0.48) NISCHOPRM1AOC3ADRB2ADRB1
SCHEMBL381817 0.82 OPRM1 (0.39) NISCHOPRM1AOC3ADRB2ADRB1
SCHEMBL382108 0.81 ALDH1A1 (0.41) NISCHOPRM1AOC3ADRB2ADRB1
SCHEMBL409383 0.81 OPRM1 (0.39) NISCHOPRM1AOC3ADRB2ADRB1
SCHEMBL167206 0.81 CNR2 (0.42) NISCHACP3
SCHEMBL14909537 0.80 SLC6A2 (0.42) AOC3
SCHEMBL1231239 0.80 SLC6A2 (0.42) AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-B1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof BAYER IP GMBH (DE) 2017-08-23 EP disclosed
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed